[Clinical evaluation of hepatitis C virus RNA quantification by competitive reverse-transcription PCR]. 1996

H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
Department of Laboratory Medicine, National Defense Medical College, Tokorozawa.

We have quantified the hepatitis C virus (HCV) RNA by competitive reverse-transcription PCR method (Amplicor) HCV quantification monitor kit) in sera with positive HCV antibody measured by means of the second generation HCV antibody assay. Among the visitors to PL Tokyo Health Control Center for their health examination and the patients to National Defense Medical College Hospital, 123 HCV antibody-positive cases were examined. A positive but low correlation between the amount of HCV-RNA and the titer of HCV antibody (r = 0.508, p value < 0.0001) was obtained. HCV-RNA was not detectable in 19 HCV antibody-positive cases. Among them, 10 cases showed normal ALT values. In the cases with more than 1000 copies/ml of HCV-RNA, the greater the amount of HCV-RNA the higher ALT values were observed, while the titer of HCV antibody was not correlated to ALT. This study demonstrated the dissociation and low correlation between HCV-RNA amount and antibody-titers in some patients, which may recommend direct quantification of RNA for clinical evaluation of the patients with positive-HCV antibody. The quantification of HCV-RNA by such rapid and simple methods can be applicable for the determination of HCV-RNA amount in routine laboratory works.

UI MeSH Term Description Entries
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
September 2000, Journal of clinical microbiology,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
January 1995, Analytical biochemistry,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
January 1999, Applied and environmental microbiology,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
January 1998, Methods in molecular biology (Clifton, N.J.),
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
May 2002, Journal of virological methods,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
April 1997, Journal of virological methods,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
July 1993, BioTechniques,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
January 2009, Methods in molecular biology (Clifton, N.J.),
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
February 1994, Journal of clinical microbiology,
H Kobayashi, and Y Takemura, and M Kamachi, and S Sekiguchi, and S Mori, and M Shioikari, and M Tamura
February 1999, Journal of clinical microbiology,
Copied contents to your clipboard!